CDKN2A and histiocytic sarcoma: Likewise, tyrosine kinase inhibitor resistance of Philadelphia chromosome-positive leukemia correlates with deletion of the CDKN2 gene (74), and cooperativity between PTEN loss and loss of Cdkn2a and Arf in histiocytic sarcoma has been reported (75).